WITH CARAC CREAM
Carac (fluorouracil) Cream, 0.5% is used by adults to treat skin conditions on the face and front part of the scalp called solar keratosis or actinic keratosis.
Important Safety Information
Carac should not be used by women who are nursing, pregnant, or may become pregnant because the drug can harm the baby or unborn baby.
Carac should not be used in patients with a condition where the body is missing an enzyme known as DPD. Although rare, the drug can cause severe stomach pain, bloody diarrhea, vomiting, fever and chills if used in these patients. Stop using the drug and contact your doctor immediately if you have any of these symptoms.
During treatment, avoid prolonged time in sunlight or exposure to other forms of ultraviolet irradiation such as sun lamps, as it may cause a stronger reaction to the drug.
Most patients using Carac get skin reactions where the medicine is used, including redness, dryness, burning, pain, erosion (loss of the upper layer of skin), and swelling. Irritation at the application site may last for two or more weeks after therapy is discontinued.
Do not use Carac on the eyes, eyelids, nostrils, or mouth. Use this medication exactly as directed by your doctor.
Please click here for Prescribing Information, including Patient Information.
*This offer is only valid for patients with commercial insurance. Eligible uninsured patients will pay more. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is good only in the U.S. at retail pharmacies owned and operated by Walgreen Co. (or its affiliates) or other participating independent retail pharmacies. This offer is not valid in Massachusetts or Minnesota or where otherwise prohibited, taxed or otherwise restricted. Click here for other terms and conditions that apply.
References: 1. Quatresooz P, Piérard-Franchimont C, Paquet P, Hubert P, Delvenne P, Piérard GE. Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues. Eur J Dermatol. 2008;18(1):6-10. 2. Berman B, Bienstock L, Kuritzky L, Mayeaux EJ Jr, Tyring SK. Actinic keratosis: sequelae and treatments. J Fam Pract. 2006;55(5)(suppl):1-8. 3. Berman B, Amini S, Valins W, Block S. Pharmacotherapy of actinic keratosis. Expert Opin Pharmacother. 2009;10(18):3015-3031. 4. Carac [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; 2012.
®/TMs are trademarks of Valeant Pharmaceuticals International, Inc. or its affiliates. Any other product or brand names and logos are the property of their respective owners.
© 2016 Valeant Pharmaceuticals North America LLC CRC.0021.USA.16